» Articles » PMID: 1612481

Virulence Properties of Escherichia Coli Strains Isolated from Patients with Inflammatory Bowel Disease

Overview
Journal Gut
Specialty Gastroenterology
Date 1992 May 1
PMID 1612481
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Escherichia coli strains cultured from 74 patients with inflammatory bowel disease at different stages of disease activity (Crohn's disease (40), ulcerative colitis (34)) and 18 healthy controls were studied in relation to haemolysin and verotoxin production and enteroadherence. Disease activity was assessed by standard clinical and laboratory tests. Haemolytic E coli were isolated from 18% of patients with Crohn's disease, 24% with ulcerative colitis, and 11% of healthy controls. None of these differences was significant. No verotoxin producing strains were detected among the 216 E coli isolates examined but the extract from five strains (Crohn's (4), ulcerative colitis (1) produced a distinctive cytopathic effort on Vero cell monolayers which was later shown not to be due to verotoxin. The adhesion indices of E coli isolates cultured were: mean (SEM) 42.2 (6.4) for Crohn's disease, 43.3 (6.2) for ulcerative colitis, and 11.3 (2.0) for normal controls (p less than or equal to 0.0001). Adhesive E coli were isolated from 62% of patients with Crohn's disease and 68% with ulcerative colitis but from only 6% of normal controls (p less than or equal to 0.0002). Neither haemolysin production nor enteroadherence was dependent upon disease activity, disease location, sulphasalazine treatment, or previous intestinal resection. These results indicate that only enteroadherent E coli were frequently associated with inflammatory bowel disease; their relation to the pathogenesis of these conditions, however, remains uncertain.

Citing Articles

Targeting Inflammation and Skin Aging via the Gut-Skin Axis: The Role of HY7714-Derived Extracellular Vesicles.

Lee H, Lee Y, Hong D, Mo S, Jeon S, Park S Microorganisms. 2025; 12(12.

PMID: 39770669 PMC: 11676968. DOI: 10.3390/microorganisms12122466.


Colibactin-driven colon cancer requires adhesin-mediated epithelial binding.

Jans M, Kolata M, Blancke G, DHondt A, Graf C, Ciers M Nature. 2024; 635(8038):472-480.

PMID: 39506107 DOI: 10.1038/s41586-024-08135-z.


Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea-From an Antioxidant Perspective.

Li Q, Zheng T, Ding H, Chen J, Li B, Zhang Q Antioxidants (Basel). 2023; 12(7).

PMID: 37507882 PMC: 10376667. DOI: 10.3390/antiox12071342.


Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates.

Zhao H, Zhang W, Cheng D, You L, Huang Y, Lu Y Front Med (Lausanne). 2022; 9:1023896.

PMID: 36438062 PMC: 9684636. DOI: 10.3389/fmed.2022.1023896.


Phylogrouping and characterization of isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran.

Nadalian B, Nadalian B, Houri H, Shahrokh S, Abdehagh M, Yadegar A Front Med (Lausanne). 2022; 9:985300.

PMID: 36106322 PMC: 9464868. DOI: 10.3389/fmed.2022.985300.


References
1.
TRUELOVE S, Witts L . Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955; 2(4947):1041-8. PMC: 1981500. DOI: 10.1136/bmj.2.4947.1041. View

2.
Burke D, Axon A . Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ. 1988; 297(6641):102-4. PMC: 1833778. DOI: 10.1136/bmj.297.6641.102. View

3.
Burke D, Axon A . Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol. 1987; 40(7):782-6. PMC: 1141098. DOI: 10.1136/jcp.40.7.782. View

4.
Levine M . Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis. 1987; 155(3):377-89. DOI: 10.1093/infdis/155.3.377. View

5.
Giaffer M, North G, HOLDSWORTH C . Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet. 1990; 335(8693):816-9. DOI: 10.1016/0140-6736(90)90936-y. View